Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 VaccineRebecca M. Shulman, Eric M. Horwitz, James Helstrom et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 23
Analysis of first-line treatment (tx) patterns in advanced non-small cell lung cancer (NSCLC) patients (pts) with compromised performance status (PS), organ dysfunction (dfxn) or other significant comorbidities.Julia Judd, Martin J. Edelman, Brinda Gupta et al.|Journal of Clinical Oncology|2021Cited by 0
First-line (1L) treatment patterns in advanced non-small cell lung cancer (NSCLC) patients (pts) who are elderly or have compromised performance status (PS).Julia Judd, Martin Joseph Edelman, Elizabeth A. Handorf et al.|Journal of Clinical Oncology|2022Cited by 0